Scholars Central

Mini reviewPublished 30 Apr 2024

Immunogenicity in Biopharmaceuticals

Authors: Louise Reagan

Department of Pharmacology, Heidelberg University, Germany

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 4 · Pages 01–02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the realm of biopharmaceuticals, ensuring therapeutic efficacy and safety is paramount. However, the immune system's response to these complex therapeutic agents, known as immunogenicity, poses a significant challenge. In this article, we delve into the intricacies of immunogenicity, exploring its causes, consequences, and strategies for mitigation in the development and administration of biopharmaceuticals.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Louise Reagan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels